Interpace Diagnostics Group, Inc. (modificare)
Versiunea de la data 1 octombrie 2024 12:13
, 1 octombrieThe LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei Interpace Diagnostics Group, Inc. listata cu simbolul US.IDXG ==Descriere companie== Interpace Biosciences, Inc. (https://www.interpace.com/) is an independent molecular diagnostics and biopharma services company. The Company is focused on providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It offers services along with the therapeutic value chain from early di...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
Interpace Biosciences, Inc. (https://www.interpace.com/) is an independent molecular diagnostics and biopharma services company. The Company is focused on providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It offers services along with the therapeutic value chain from early diagnosis and prognostic planning to target therapeutic applications through its clinical and pharma services. Its clinical services provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. Its pharma services provide pharmacogenomics testing, genotyping, biorepository and other services to the pharmaceutical and biotech industries. The Company's products include ThyGenNEXT, ThyraMIR, PancraGEN, RespriDX and BarreGen. | Interpace Biosciences, Inc. (https://www.interpace.com/) is an independent molecular diagnostics and biopharma services company. The Company is focused on providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It offers services along with the therapeutic value chain from early diagnosis and prognostic planning to target therapeutic applications through its clinical and [[PHARMA|pharma]] services. Its clinical services provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. Its pharma services provide pharmacogenomics testing, genotyping, biorepository and other services to the pharmaceutical and biotech industries. The Company's products include ThyGenNEXT, ThyraMIR, PancraGEN, RespriDX and BarreGen. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||